Association between preexisting mental illnesses and mortality among medicaid-insured women diagnosed with breast cancer.

Abstract

We investigated the impact of preexisting mental illnesses on all-cause and cause-specific mortality among Medicaid-insured women diagnosed with breast cancer. Data from the New York State Cancer Registry for 10,444 women diagnosed with breast cancer from 2004 to 2016 and aged <65yearsat diagnosis were linked with Medicaid claims. Women were categorized as having depression or a severe mental illness (SMI) if they had at least three relevant diagnosis claims with at least one claim within three years prior to breast cancer diagnosis. SMI included schizophrenia, bipolar disorder, and other psychotic disorders. Estimated menopausal status was determined by age (premenopausal age <50; postmenopausal age ≥50). Hazard ratios (HR) and 95% confidence intervals (95%CI) were calculated with Cox proportional hazards regression, adjusting for potential confounders. Preexisting SMI was associated with greater all-cause (HR=1.36; 95%CI 1.18, 1.57) and cancer-specific (HR=1.21; 95%CI 1.03, 1.44) mortality compared to those with no mental illnesses. No association was observed between preexisting depression and mortality. Among racial/ethnic subgroups, the association between SMI and all-cause mortality was observed among non-Hispanic white (HR=1.47; 95%CI 1.19, 1.83) and non-Hispanic Asian/Pacific Islander (HR=2.59; 95% 1.15, 5.87) women. Additionally, mortality hazards were greatest among women with preexisting SMI that were postmenopausal (HR=1.49; 95%CI 1.25, 1.78), obese (HR=1.58; 95%CI 1.26, 1.98), and had documented tobacco use (HR=1.42; 95%CI 1.13, 1.78). Women with preexisting SMI prior to breast cancer diagnosis have an elevated mortality hazard and should be monitored and treated by a coordinated cross-functional clinical team.